Consensus Bath & Body Works, Inc.

Equities

BBWI

US0708301041

Market Closed - Nyse 04:00:02 2024-04-26 pm EDT 5-day change 1st Jan Change
46.04 USD +0.96% Intraday chart for Bath & Body Works, Inc. +4.66% +6.67%

Evolution of the average Target Price on Bath & Body Works, Inc.

Price target over the last 5 years

History of analyst recommendation changes

7.QI9p7cF424FBVGpwjmx4bRcKeTO0EX_quERADE0l0EQ.LOMwiPIKo7gPCw0g7CZIGHNbAX3rZDW-3RxtRgAQlxIa1S-UrD6i6hM4CQ~41e95dbf24d84645f803c5ddff461c5f
Wells Fargo Adjusts Bath & Body Works' Price Target to $48 From $42, Keeps Equalweight Rating MT
Piper Sandler Raises Price Target on Bath & Body Works to $45 From $44, Maintains Neutral Rating MT
Goldman Sachs Raises Price Target on Bath & Body Works to $56 From $49, Maintains Buy Rating MT
UBS Raises Bath & Body Works Price Target to $52 From $46, Maintains Neutral Rating MT
Deutsche Bank Adjusts Bath & Body Works Price Target to $53 From $55, Maintains Buy Rating MT
Telsey Advisory Adjusts Bath & Body Works' Price Target to $53 From $50, Maintains Outperform Rating MT
TD Cowen Raises Price Target on Bath & Body Works to $55 From $35, Keeps Outperform Rating MT
Evercore ISI Raises Bath & Body Works Price Target to $45 From $30, Maintains In Line Rating MT
Deutsche Bank Adjusts Bath & Body Works Price Target to $55 From $49, Maintains Buy Rating MT
UBS Adjusts Bath & Body Works Price Target to $46 From $44, Maintains Neutral Rating MT
Morgan Stanley Boosts Price Target on Bath & Body Works to $52 From $50, Keeps Overweight Rating MT
UBS Raises Price Target on Bath & Body Works to $44 From $34, Keeps Neutral Rating MT
Barclays Downgrades Bath & Body Works to Equalweight From Overweight, Raises Price Target to $45 From $37 MT
Wells Fargo Raises Bath & Body Works' Price Target to $40 From $35, Keeps Equalweight Rating MT
Goldman Sachs Trims Price Target on Bath & Body Works to $49 From $52, Keeps Buy Rating MT
Deutsche Bank Cuts Bath & Body Works Price Target to $44 From $47, Maintains Buy Rating MT
Telsey Advisory Group Cuts Bath & Body Works Price Target to $42 From $52, Maintains Outperform Rating MT
UBS Cuts Bath & Body Works Price Target to $34 From $39, Maintains Neutral Rating MT
Jefferies Downgrades Bath & Body Works to Hold From Buy, Adjusts Price Target to $30 From $45 MT
JPMorgan Downgrades Bath & Body Works to Underweight From Neutral, Cuts Price Target to $27 From $41 MT
Raymond James Cuts Price Target on Bath & Body Works to $40 From $48, Maintains Outperform Rating MT
Goldman Sachs Raises Price Target on Bath & Body Works to $52 From $50, Maintains Buy Rating MT
UBS Adjusts Bath & Body Works Price Target to $39 From $38, Maintains Neutral Rating MT
Citigroup Adjusts Bath & Body Works' Price Target to $40 From $38, Keeps Neutral Rating MT
Bulls are still here Our Logo
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
46.04 USD
Average target price
51.66 USD
Spread / Average Target
+12.21%
High Price Target
73 USD
Spread / Highest target
+58.56%
Low Price Target
40 USD
Spread / Lowest Target
-13.12%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Bath & Body Works, Inc.

Wells Fargo Securities
Piper Sandler
Goldman Sachs
UBS
Deutsche Bank Securities
Telsey Advisory Group
TD Cowen
Evercore ISI
Morgan Stanley
Barclays
Jefferies & Co.
JPMorgan Chase
Raymond James
Citigroup
Argus
Credit Suisse
Cowen
Baird
BofA Securities
BMO Capital
B. Riley
MKM Partners
Atlantic Equities
Morningstar
RBC Capital Markets
J.P. Morgan Chase
KeyBanc Capital Markets
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
  1. Stock Market
  2. Equities
  3. BBWI Stock
  4. Consensus Bath & Body Works, Inc.